ADMA logo

ADMA Biologics (ADMA) Gross Profit

ADMA Annual Gross Profit

$88.94 M
+$53.68 M+152.21%

31 December 2023

ADMA Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Quarterly Gross Profit

$59.66 M
+$2.21 M+3.84%

30 September 2024

ADMA Quarterly Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA TTM Gross Profit

$187.31 M
+$35.01 M+22.98%

30 September 2024

ADMA TTM Gross Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Gross Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+152.2%+142.0%+160.0%
3 y3 years+566.4%+320.8%+431.1%
5 y5 years+452.8%+320.8%+431.1%

ADMA Gross Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7482.4%at high+1599.1%at high>+9999.0%
5 y5-yearat high+566.4%at high+999.9%at high+1082.1%
alltimeall timeat high+452.8%at high+827.5%at high+843.0%

ADMA Biologics Gross Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
$59.66 M(+3.8%)
$187.31 M(+23.0%)
June 2024
-
$57.45 M(+46.9%)
$152.30 M(+36.5%)
Mar 2024
-
$39.11 M(+25.8%)
$111.54 M(+25.4%)
Dec 2023
$88.94 M(+152.2%)
$31.09 M(+26.1%)
$88.94 M(+23.5%)
Sept 2023
-
$24.65 M(+47.7%)
$72.03 M(+26.3%)
June 2023
-
$16.69 M(+1.1%)
$57.04 M(+18.5%)
Mar 2023
-
$16.51 M(+16.5%)
$48.12 M(+36.4%)
Dec 2022
$35.27 M(+2906.4%)
$14.18 M(+46.8%)
$35.26 M(+43.4%)
Sept 2022
-
$9.66 M(+24.3%)
$24.60 M(+60.5%)
June 2022
-
$7.77 M(+112.2%)
$15.33 M(+133.8%)
Mar 2022
-
$3.66 M(+4.3%)
$6.56 M(+459.0%)
Dec 2021
$1.17 M(-106.2%)
$3.51 M(+811.3%)
$1.17 M(-115.7%)
Sept 2021
-
$385.30 K(-138.5%)
-$7.49 M(-20.8%)
June 2021
-
-$1.00 M(-41.8%)
-$9.46 M(-33.2%)
Mar 2021
-
-$1.72 M(-66.6%)
-$14.16 M(-25.7%)
Dec 2020
-$19.07 M(+87.8%)
-$5.16 M(+226.5%)
-$19.07 M(+40.5%)
Sept 2020
-
-$1.58 M(-72.3%)
-$13.57 M(+7.0%)
June 2020
-
-$5.71 M(-13.9%)
-$12.69 M(+16.3%)
Mar 2020
-
-$6.63 M(-2019.4%)
-$10.91 M(+7.4%)
Dec 2019
-$10.16 M(-59.7%)
$345.40 K(-149.8%)
-$10.16 M(-42.3%)
Sept 2019
-
-$693.70 K(-82.3%)
-$17.59 M(-19.4%)
June 2019
-
-$3.93 M(-33.1%)
-$21.83 M(-4.6%)
Mar 2019
-
-$5.88 M(-17.1%)
-$22.89 M(-9.2%)
Dec 2018
-$25.21 M(+293.7%)
-$7.09 M(+43.6%)
-$25.21 M(+39.7%)
Sept 2018
-
-$4.93 M(-1.1%)
-$18.04 M(-8.3%)
June 2018
-
-$4.99 M(-39.2%)
-$19.67 M(+26.0%)
Mar 2018
-
-$8.20 M(<-9900.0%)
-$15.62 M(+143.9%)
Dec 2017
-$6.40 M
$80.00 K(-101.2%)
-$6.40 M(+23.9%)
Sept 2017
-
-$6.56 M(+602.1%)
-$5.17 M(-299.4%)
June 2017
-
-$934.60 K(-192.3%)
$2.59 M(-41.8%)
DateAnnualQuarterlyTTM
Mar 2017
-
$1.01 M(-22.9%)
$4.46 M(+3.6%)
Dec 2016
$4.30 M(+50.0%)
$1.31 M(+9.2%)
$4.30 M(+7.6%)
Sept 2016
-
$1.20 M(+29.6%)
$4.00 M(+13.1%)
June 2016
-
$927.50 K(+8.2%)
$3.53 M(+12.9%)
Mar 2016
-
$857.50 K(-15.0%)
$3.13 M(+9.2%)
Dec 2015
$2.87 M(+31.9%)
$1.01 M(+36.5%)
$2.87 M(+20.0%)
Sept 2015
-
$739.60 K(+41.3%)
$2.39 M(+11.2%)
June 2015
-
$523.60 K(-11.8%)
$2.15 M(-1.6%)
Mar 2015
-
$593.50 K(+11.6%)
$2.18 M(+0.5%)
Dec 2014
$2.17 M(+108.1%)
$531.90 K(+6.8%)
$2.17 M(+21.9%)
Sept 2014
-
$498.20 K(-11.0%)
$1.78 M(+7.0%)
June 2014
-
$559.50 K(-4.1%)
$1.67 M(+22.1%)
Mar 2014
-
$583.50 K(+312.1%)
$1.36 M(+30.6%)
Dec 2013
$1.04 M(+132.5%)
$141.60 K(-62.8%)
$1.04 M(-0.1%)
Sept 2013
-
$381.10 K(+48.0%)
$1.05 M(+18.8%)
June 2013
-
$257.50 K(-2.4%)
$880.00 K(+23.8%)
Mar 2013
-
$263.90 K(+84.5%)
$710.70 K(+57.5%)
Dec 2012
$449.10 K(>+9900.0%)
$143.00 K(-33.7%)
$451.20 K(+46.4%)
Sept 2012
-
$215.60 K(+144.4%)
$308.20 K(+232.8%)
June 2012
-
$88.20 K(+1904.5%)
$92.60 K(+2004.5%)
Mar 2012
-
$4400.00(>+9900.0%)
$4400.00(>+9900.0%)
Dec 2011
-
$0.00(0.0%)
$0.00(0.0%)
Sept 2011
-
$0.00(0.0%)
$0.00(0.0%)
June 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2010
-
$0.00(0.0%)
$0.00(0.0%)
Sept 2010
-
$0.00(0.0%)
$0.00(0.0%)
June 2010
-
$0.00(0.0%)
$0.00(0.0%)
June 2010
$0.00
-
-
Mar 2010
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2009
-
$0.00
$0.00

FAQ

  • What is ADMA Biologics annual gross profit?
  • What is the all time high annual gross profit for ADMA Biologics?
  • What is ADMA Biologics annual gross profit year-on-year change?
  • What is ADMA Biologics quarterly gross profit?
  • What is the all time high quarterly gross profit for ADMA Biologics?
  • What is ADMA Biologics quarterly gross profit year-on-year change?
  • What is ADMA Biologics TTM gross profit?
  • What is the all time high TTM gross profit for ADMA Biologics?
  • What is ADMA Biologics TTM gross profit year-on-year change?

What is ADMA Biologics annual gross profit?

The current annual gross profit of ADMA is $88.94 M

What is the all time high annual gross profit for ADMA Biologics?

ADMA Biologics all-time high annual gross profit is $88.94 M

What is ADMA Biologics annual gross profit year-on-year change?

Over the past year, ADMA annual gross profit has changed by +$53.68 M (+152.21%)

What is ADMA Biologics quarterly gross profit?

The current quarterly gross profit of ADMA is $59.66 M

What is the all time high quarterly gross profit for ADMA Biologics?

ADMA Biologics all-time high quarterly gross profit is $59.66 M

What is ADMA Biologics quarterly gross profit year-on-year change?

Over the past year, ADMA quarterly gross profit has changed by +$35.01 M (+141.99%)

What is ADMA Biologics TTM gross profit?

The current TTM gross profit of ADMA is $187.31 M

What is the all time high TTM gross profit for ADMA Biologics?

ADMA Biologics all-time high TTM gross profit is $187.31 M

What is ADMA Biologics TTM gross profit year-on-year change?

Over the past year, ADMA TTM gross profit has changed by +$115.27 M (+160.03%)